Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

RELMα Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling.

Lin Q, Fan C, Skinner JT, Hunter EN, Macdonald AA, Illei PB, Yamaji-Kegan K, Johns RA.

J Immunol. 2019 Oct 14. pii: ji1900535. doi: 10.4049/jimmunol.1900535. [Epub ahead of print]

PMID:
31611261
2.

Results from the 2019 American Society of Cytopathology survey on rapid on-site evaluation-Part 1: objective practice patterns.

VanderLaan PA, Chen Y, Alex D, Balassanian R, Cuda J, Hoda RS, Illei PB, McGrath CM, Randolph ML, Reynolds JP, Spiczka AJ, VandeHaar MA, van Zante A, Sauter JL; American Society of Cytopathology Clinical Practice Committee.

J Am Soc Cytopathol. 2019 Nov - Dec;8(6):333-341. doi: 10.1016/j.jasc.2019.07.007. Epub 2019 Aug 8.

PMID:
31495750
3.

Mucocele Presenting as Polypoid Bronchoscopic Lesion with Post-Obstructive Pneumonia.

Shafiq M, Thompson E, Illei P, Yarmus L.

Lung. 2019 Oct;197(5):681-682. doi: 10.1007/s00408-019-00259-8. Epub 2019 Aug 10. No abstract available.

PMID:
31401685
4.

Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens.

Tseng LH, De Marchi F, Pallavajjalla A, Rodriguez E, Xian R, Belchis D, Gocke CD, Eshleman JR, Illei P, Lin MT.

Am J Clin Pathol. 2019 Oct 7;152(5):570-581. doi: 10.1093/ajcp/aqz077.

PMID:
31264684
5.

Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

Anagnostou V, Forde PM, White JR, Niknafs N, Hruban C, Naidoo J, Marrone K, Sivakumar IKA, Bruhm DC, Rosner S, Phallen J, Leal A, Adleff V, Smith KN, Cottrell TR, Rhymee L, Palsgrove DN, Hann CL, Levy B, Feliciano J, Georgiades C, Verde F, Illei P, Li QK, Gabrielson E, Brock MV, Isbell JM, Sauter JL, Taube J, Scharpf RB, Karchin R, Pardoll DM, Chaft JE, Hellmann MD, Brahmer JR, Velculescu VE.

Cancer Res. 2019 Mar 15;79(6):1214-1225. doi: 10.1158/0008-5472.CAN-18-1127. Epub 2018 Dec 12.

6.

Clinical Validation of Coexisting Activating Mutations Within EGFR, Mitogen-Activated Protein Kinase, and Phosphatidylinositol 3-Kinase Pathways in Lung Cancers.

De Marchi F, Haley L, Fryer H, Ibrahim J, Beierl K, Zheng G, Gocke CD, Eshleman JR, Belchis D, Illei P, Lin MT.

Arch Pathol Lab Med. 2019 Feb;143(2):174-182. doi: 10.5858/arpa.2017-0495-OA. Epub 2018 Sep 7.

PMID:
30485130
7.

Clinical Validation of Coexisting Activating Mutations Within EGFR, Mitogen-Activated Protein Kinase, and Phosphatidylinositol 3-Kinase Pathways in Lung Cancers.

De Marchi F, Haley L, Fryer H, Ibrahim J, Beierl K, Zheng G, Gocke CD, Eshleman JR, Belchis D, Illei P, Lin MT.

Arch Pathol Lab Med. 2018 Sep 7. doi: 10.5858/arpa.2018-0495-OA. [Epub ahead of print]

PMID:
30192171
8.

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).

Cottrell TR, Thompson ED, Forde PM, Stein JE, Duffield AS, Anagnostou V, Rekhtman N, Anders RA, Cuda JD, Illei PB, Gabrielson E, Askin FB, Niknafs N, Smith KN, Velez MJ, Sauter JL, Isbell JM, Jones DR, Battafarano RJ, Yang SC, Danilova L, Wolchok JD, Topalian SL, Velculescu VE, Pardoll DM, Brahmer JR, Hellmann MD, Chaft JE, Cimino-Mathews A, Taube JM.

Ann Oncol. 2018 Aug 1;29(8):1853-1860. doi: 10.1093/annonc/mdy218.

9.

Rediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profiling.

Baras AS, Naidoo J, Hann CL, Illei PB, Reninger CW, Lauring J.

J Natl Compr Canc Netw. 2018 May;16(5):467-472. doi: 10.6004/jnccn.2017.7203.

PMID:
29752320
10.

Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.

Xing D, Banet N, Sharma R, Vang R, Ronnett BM, Illei PB.

Hum Pathol. 2018 Feb;72:160-166. doi: 10.1016/j.humpath.2017.10.036. Epub 2017 Dec 11.

PMID:
29241740
11.

Clinical mutational profiling of 1006 lung cancers by next generation sequencing.

Illei PB, Belchis D, Tseng LH, Nguyen D, De Marchi F, Haley L, Riel S, Beierl K, Zheng G, Brahmer JR, Askin FB, Gocke CD, Eshleman JR, Forde PM, Lin MT.

Oncotarget. 2017 May 20;8(57):96684-96696. doi: 10.18632/oncotarget.18042. eCollection 2017 Nov 14.

12.

INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.

Rooper LM, Sharma R, Li QK, Illei PB, Westra WH.

Am J Surg Pathol. 2017 Nov;41(11):1561-1569. doi: 10.1097/PAS.0000000000000916.

PMID:
28719469
13.

Expression of GULP1 in bronchial epithelium is associated with the progression of emphysema in chronic obstructive pulmonary disease.

Datta S, Nam HS, Hayashi M, Maldonado L, Goldberg R, Brait M, Sidransky D, Illei P, Baras A, Vij N, Hoque MO.

Respir Med. 2017 Mar;124:72-78. doi: 10.1016/j.rmed.2017.02.011. Epub 2017 Feb 17.

14.

mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis.

Hallowell RW, Collins SL, Craig JM, Zhang Y, Oh M, Illei PB, Chan-Li Y, Vigeland CL, Mitzner W, Scott AL, Powell JD, Horton MR.

Nat Commun. 2017 Jan 27;8:14208. doi: 10.1038/ncomms14208.

15.

The utility of bronchial brushings in the modern era of flexible bronchoscopy.

VandenBussche CJ, Yarmus L, Illei PB.

J Am Soc Cytopathol. 2017 Jan - Feb;6(1):1-7. doi: 10.1016/j.jasc.2016.09.001. Epub 2016 Oct 25.

PMID:
31042627
16.

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

Anagnostou V, Smith KN, Forde PM, Niknafs N, Bhattacharya R, White J, Zhang T, Adleff V, Phallen J, Wali N, Hruban C, Guthrie VB, Rodgers K, Naidoo J, Kang H, Sharfman W, Georgiades C, Verde F, Illei P, Li QK, Gabrielson E, Brock MV, Zahnow CA, Baylin SB, Scharpf RB, Brahmer JR, Karchin R, Pardoll DM, Velculescu VE.

Cancer Discov. 2017 Mar;7(3):264-276. doi: 10.1158/2159-8290.CD-16-0828. Epub 2016 Dec 28.

17.

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.

Kim HS, Umbricht CB, Illei PB, Cimino-Mathews A, Cho S, Chowdhury N, Figueroa-Magalhaes MC, Pesce C, Jeter SC, Mylander C, Rosman M, Tafra L, Turner BM, Hicks DG, Jensen TA, Miller DV, Armstrong DK, Connolly RM, Fetting JH, Miller RS, Park BH, Stearns V, Visvanathan K, Wolff AC, Cope L.

J Clin Oncol. 2016 Dec 20;34(36):4390-4397. Epub 2016 Oct 31.

18.

Stylet Use Does Not Improve Diagnostic Outcomes in Endobronchial Ultrasonographic Transbronchial Needle Aspiration: A Randomized Clinical Trial.

Scholten EL, Semaan R, Illei P, Mallow C, Arias S, Feller-Kopman D, Oakjones-Burgess K, Frimpong B, Ortiz R, Lee H, Yarmus L.

Chest. 2017 Mar;151(3):636-642. doi: 10.1016/j.chest.2016.10.005. Epub 2016 Oct 18.

19.

Complex Sources of Variation in Tissue Expression Data: Analysis of the GTEx Lung Transcriptome.

McCall MN, Illei PB, Halushka MK.

Am J Hum Genet. 2016 Sep 1;99(3):624-635. doi: 10.1016/j.ajhg.2016.07.007.

20.

Heterogeneity of resistance mutations detectable by nextgeneration sequencing in TKI-treated lung adenocarcinoma.

Belchis DA, Tseng LH, Gniadek T, Haley L, Lokhandwala P, Illei P, Gocke CD, Forde P, Brahmer J, Askin FB, Eshleman JR, Lin MT.

Oncotarget. 2016 Jul 19;7(29):45237-45248. doi: 10.18632/oncotarget.9931.

21.

Clinical mutational profiling of bone metastases of lung and colon carcinoma and malignant melanoma using next-generation sequencing.

Zheng G, Lin MT, Lokhandwala PM, Beierl K, Netto GJ, Gocke CD, Eshleman JR, McCarthy E, Illei PB.

Cancer Cytopathol. 2016 Oct;124(10):744-753. doi: 10.1002/cncy.21743. Epub 2016 Jun 10.

22.

Bronchus-associated Lymphoid Tissue in Kabuki Syndrome with Associated Hyper-IgM Syndrome/Common Variable Immunodeficiency.

Mock JR, Kolb TM, Illei PB, Yang SC, Lederman HM, Merlo CA.

Am J Respir Crit Care Med. 2016 Aug 15;194(4):514-5. doi: 10.1164/rccm.201511-2305IM. No abstract available.

23.

Test Feasibility of Next-Generation Sequencing Assays in Clinical Mutation Detection of Small Biopsy and Fine Needle Aspiration Specimens.

Zheng G, Tsai H, Tseng LH, Illei P, Gocke CD, Eshleman JR, Netto G, Lin MT.

Am J Clin Pathol. 2016 May;145(5):696-702. doi: 10.1093/ajcp/aqw043.

24.

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy.

Illei PB, Alewine C, Zahurak M, Cowan ML, Montgomery E, Hassan R, Xiang L, Pastan I, Kelly RJ.

Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):246-52. doi: 10.1097/PAI.0000000000000292.

25.

A Randomized Controlled Trial of a Novel Sheath Cryoprobe for Bronchoscopic Lung Biopsy in a Porcine Model.

Yarmus LB, Semaan RW, Arias SA, Feller-Kopman D, Ortiz R, Bösmüller H, Illei PB, Frimpong BO, Oakjones-Burgess K, Lee HJ.

Chest. 2016 Aug;150(2):329-36. doi: 10.1016/j.chest.2016.01.018. Epub 2016 Jan 30.

PMID:
26836935
26.

Clinical detection and categorization of uncommon and concomitant mutations involving BRAF.

Zheng G, Tseng LH, Chen G, Haley L, Illei P, Gocke CD, Eshleman JR, Lin MT.

BMC Cancer. 2015 Oct 24;15:779. doi: 10.1186/s12885-015-1811-y.

27.

CDX-2 Expression in Primary Lung Adenocarcinoma.

Cowan ML, Li QK, Illei PB.

Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):16-9. doi: 10.1097/PAI.0000000000000250.

PMID:
26469326
28.

Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool.

Carter J, Tseng LH, Zheng G, Dudley J, Illei P, Gocke CD, Eshleman JR, Lin MT.

Am J Clin Pathol. 2015 Oct;144(4):620-8. doi: 10.1309/AJCP85ATMJOZOUDJ.

PMID:
26386083
29.

Metastatic metaplastic breast carcinoma mimicking pulmonary squamous cell carcinoma on fine-needle aspiration.

Nguyen DN, Kawamoto S, Cimino-Mathews A, Illei PB, Rosenthal DL, VandenBussche CJ.

Diagn Cytopathol. 2015 Oct;43(10):844-9. doi: 10.1002/dc.23321. Epub 2015 Aug 3.

PMID:
26238413
30.

SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial.

Hidalgo M, Plaza C, Musteanu M, Illei P, Brachmann CB, Heise C, Pierce D, Lopez-Casas PP, Menendez C, Tabernero J, Romano A, Wei X, Lopez-Rios F, Von Hoff DD.

Clin Cancer Res. 2015 Nov 1;21(21):4811-8. doi: 10.1158/1078-0432.CCR-14-3222. Epub 2015 Jul 13. Erratum in: Clin Cancer Res. 2016 Dec 15;22(24):6302.

31.

Human Herpesvirus 8-Related Primary Effusion Lymphoma After Liver Transplantation.

Christenson ES, Teply B, Agrawal V, Illei P, Gurakar A, Kanakry JA.

Am J Transplant. 2015 Oct;15(10):2762-6. doi: 10.1111/ajt.13321. Epub 2015 May 18.

32.

Smooth muscle and adenoma-like renal tumor: a previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?

Smith NE, Epstein JI, Parwani AV, Netto GJ, Illei PB, Powell K, Allaf ME, Argani P.

Hum Pathol. 2015 Jun;46(6):894-905. doi: 10.1016/j.humpath.2015.02.003. Epub 2015 Feb 19.

PMID:
25911262
33.

Bronchiolitis obliterans organizing pneumonia following a jalapeño grease fire.

Garibaldi BT, West NE, Illei PB, Terry PB.

Chest. 2015 Feb;147(2):e31-e33. doi: 10.1378/chest.14-1338.

PMID:
25644912
34.

ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.

Uchida K, Ross H, Lotan T, Pignon JC, Signoretti S, Epstein JI, Illei PB.

Hum Pathol. 2015 Mar;46(3):384-9. doi: 10.1016/j.humpath.2014.11.011. Epub 2014 Dec 2.

PMID:
25548110
35.

Molecular alterations in non-small cell lung carcinomas of the young.

VandenBussche CJ, Illei PB, Lin MT, Ettinger DS, Maleki Z.

Hum Pathol. 2014 Dec;45(12):2379-87. doi: 10.1016/j.humpath.2014.08.005. Epub 2014 Sep 2.

PMID:
25288236
36.

A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.

Cimino-Mathews A, Sharma R, Illei PB, Vang R, Argani P.

Am J Surg Pathol. 2014 Dec;38(12):1689-96. doi: 10.1097/PAS.0000000000000301.

37.

NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.

Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong AP, Sharma R, Illei PB, Argani P, Cimino-Mathews A.

J Clin Pathol. 2014 Sep;67(9):768-71.

38.

Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Dutta NK, Illei PB, Jain SK, Karakousis PC.

Am J Pathol. 2014 Jul;184(7):2045-55. doi: 10.1016/j.ajpath.2014.03.008. Epub 2014 May 9.

39.

Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopy.

Wang H, Sima CS, Beasley MB, Illei P, Saqi A, Nonaka D, Geisinger KR, Huang J, Moreira AL.

Arch Pathol Lab Med. 2014 May;138(5):658-63. doi: 10.5858/arpa.2013-0028-OA.

PMID:
24786123
40.

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.

Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK.

Hum Pathol. 2014 May;45(5):926-34. doi: 10.1016/j.humpath.2014.01.005. Epub 2014 Jan 25.

41.

The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex.

Heikamp EB, Patel CH, Collins S, Waickman A, Oh MH, Sun IH, Illei P, Sharma A, Naray-Fejes-Toth A, Fejes-Toth G, Misra-Sen J, Horton MR, Powell JD.

Nat Immunol. 2014 May;15(5):457-64. doi: 10.1038/ni.2867. Epub 2014 Apr 6.

42.

VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?

Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P.

Am J Surg Pathol. 2014 Jun;38(6):858-63. doi: 10.1097/PAS.0000000000000179.

43.

Raynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.

Stojan G, Illei PB, Yung RC, Gelber AC.

Arthritis Care Res (Hoboken). 2014 Aug;66(8):1263-8. doi: 10.1002/acr.22331. No abstract available.

44.

t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.

Smith NE, Illei PB, Allaf M, Gonzalez N, Morris K, Hicks J, Demarzo A, Reuter VE, Amin MB, Epstein JI, Netto GJ, Argani P.

Am J Surg Pathol. 2014 May;38(5):604-14. doi: 10.1097/PAS.0000000000000203.

45.

Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report.

Forde PM, Hooker CM, Boikos SA, Petrini I, Giaccone G, Rudin CM, Yang SC, Illei PB, Hann CL, Ettinger DS, Brahmer JR, Kelly RJ.

J Thorac Oncol. 2014 Mar;9(3):414-8. doi: 10.1097/JTO.0000000000000065.

46.

Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease.

Stojan G, Melia MT, Khandhar SJ, Illei P, Baer AN.

BMC Infect Dis. 2013 Dec 9;13:579. doi: 10.1186/1471-2334-13-579.

47.

The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.

Gonzalez-Roibon N, Albadine R, Sharma R, Faraj SF, Illei PB, Argani P, Ertoy D, Allaf ME, Netto GJ.

Hum Pathol. 2013 Dec;44(12):2651-7. doi: 10.1016/j.humpath.2013.07.006. Epub 2013 Sep 24.

PMID:
24071011
48.

Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases.

Lee S, Illei PB, Han JS, Epstein JI.

Am J Surg Pathol. 2014 Jan;38(1):54-9. doi: 10.1097/PAS.0b013e31829ab20e.

PMID:
24061516
49.

Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype.

VandenBussche CJ, Elwood H, Cimino-Mathews A, Bittar Z, Illei PB, Warzecha HN.

Hum Pathol. 2013 Nov;44(11):2487-93. doi: 10.1016/j.humpath.2013.06.007. Epub 2013 Sep 10.

PMID:
24029706
50.

A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.

Cimino-Mathews A, Hicks JL, Sharma R, Vang R, Illei PB, De Marzo A, Emens LA, Argani P.

Hum Pathol. 2013 Nov;44(11):2494-500. doi: 10.1016/j.humpath.2013.06.009. Epub 2013 Jul 31.

Supplemental Content

Support Center